IRIS
PASSINO, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 55.016
EU - Europa 33.191
AS - Asia 26.659
SA - Sud America 5.450
Continente sconosciuto - Info sul continente non disponibili 779
AF - Africa 661
OC - Oceania 144
Totale 121.900
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 51.888
SG - Singapore 9.635
IT - Italia 7.289
GB - Regno Unito 7.259
RU - Federazione Russa 7.232
CN - Cina 6.696
BR - Brasile 4.235
VN - Vietnam 3.649
UA - Ucraina 2.336
CA - Canada 2.326
DE - Germania 2.309
HK - Hong Kong 1.982
BD - Bangladesh 1.755
DK - Danimarca 1.529
FR - Francia 1.131
SE - Svezia 1.009
FI - Finlandia 836
IN - India 569
IE - Irlanda 549
PL - Polonia 539
MX - Messico 481
AR - Argentina 437
NL - Olanda 391
TR - Turchia 327
IL - Israele 278
ID - Indonesia 254
EC - Ecuador 225
IQ - Iraq 216
ZA - Sudafrica 211
PK - Pakistan 208
JP - Giappone 206
ES - Italia 191
CO - Colombia 147
VE - Venezuela 120
AT - Austria 115
AU - Australia 108
EU - Europa 106
UZ - Uzbekistan 100
MA - Marocco 98
SA - Arabia Saudita 91
CL - Cile 88
KR - Corea 77
IR - Iran 72
AE - Emirati Arabi Uniti 70
PY - Paraguay 67
EG - Egitto 66
MY - Malesia 66
KE - Kenya 64
LT - Lituania 62
CR - Costa Rica 60
PH - Filippine 60
PE - Perù 57
JM - Giamaica 53
TN - Tunisia 52
RO - Romania 48
JO - Giordania 46
DZ - Algeria 42
BE - Belgio 41
CH - Svizzera 41
HN - Honduras 39
NP - Nepal 37
PT - Portogallo 36
BO - Bolivia 34
SK - Slovacchia (Repubblica Slovacca) 34
NZ - Nuova Zelanda 33
UY - Uruguay 33
TH - Thailandia 32
AZ - Azerbaigian 31
ET - Etiopia 30
CZ - Repubblica Ceca 28
TT - Trinidad e Tobago 25
KZ - Kazakistan 24
GR - Grecia 23
TW - Taiwan 23
NI - Nicaragua 22
GT - Guatemala 21
DO - Repubblica Dominicana 18
KG - Kirghizistan 18
HU - Ungheria 17
PS - Palestinian Territory 17
AL - Albania 16
OM - Oman 16
PA - Panama 16
QA - Qatar 15
PR - Porto Rico 14
GE - Georgia 13
SV - El Salvador 13
AM - Armenia 12
BB - Barbados 12
LV - Lettonia 12
NO - Norvegia 12
RS - Serbia 12
BY - Bielorussia 11
MK - Macedonia 11
SN - Senegal 11
BG - Bulgaria 10
BH - Bahrain 10
CI - Costa d'Avorio 10
KW - Kuwait 10
LB - Libano 10
Totale 121.016
Salva come PNG Salva come JPEG
Città #
Dallas 8.067
Southend 4.837
Singapore 4.811
Ashburn 3.312
San Jose 3.194
Beijing 2.762
Woodbridge 2.678
Chandler 2.320
Ann Arbor 2.295
Houston 2.134
Hong Kong 1.761
Fairfield 1.626
Council Bluffs 1.485
San Mateo 1.470
Moscow 1.302
Falls Church 1.263
Jacksonville 1.113
Los Angeles 1.110
Seattle 1.098
Dearborn 1.020
Milan 1.019
Ho Chi Minh City 993
Cambridge 971
Wilmington 902
Ottawa 866
The Dalles 791
New York 779
Rome 696
Chicago 659
Pisa 649
Hanoi 631
Santa Clara 612
Boardman 553
Hefei 541
Dublin 521
Lauterbourg 513
Stevenage 512
Portsmouth 503
Warsaw 492
Dong Ket 483
Buffalo 456
São Paulo 456
Helsinki 425
Montréal 403
Lawrence 386
Brooklyn 327
Beauharnois 315
London 256
Tel Aviv 249
Munich 244
Orem 244
Salt Lake City 234
Phoenix 228
Florence 216
Mexico City 214
Montreal 211
Frankfurt am Main 184
San Diego 177
Redwood City 175
Toronto 168
Tokyo 166
Denver 158
Old Bridge 158
Columbus 155
Stockholm 151
Atlanta 150
Chennai 150
Istanbul 148
Rio de Janeiro 145
Figino 140
Poplar 139
Da Nang 134
Naples 134
Amsterdam 133
Johannesburg 132
Haiphong 119
Boston 115
Elk Grove Village 115
Tampa 115
Fremont 112
Nuremberg 112
Turin 112
Bologna 102
Manchester 95
Tashkent 90
San Francisco 88
Ankara 78
Shanghai 77
Washington 76
Belo Horizonte 74
Biên Hòa 72
Brasília 72
Curitiba 71
Mumbai 71
Guayaquil 69
Baghdad 68
Norwalk 68
Paris 68
Quito 68
Dhaka 67
Totale 73.279
Salva come PNG Salva come JPEG
Nome #
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.713
Value in Healthcare and the Role of the Patient Voice 1.232
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 703
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 633
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 625
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 521
E-Health in Tuscany Inner Areas: The PROXIMITY-CARE Approach 511
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 496
Impact of GFR Estimation Formulas on MECKI Score Performance and Prognostic Accuracy in Heart Failure: The MECKI-RENAL Study 495
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 459
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 456
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 435
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 405
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 405
A simple echocardiographic score to rule out cardiac amyloidosis 398
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 396
A simple echocardiographic score to rule out cardiac amyloidosis 388
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 376
Human pathophysiological adaptations to the space environment 375
Grapevine microRNAs in an in vitro model of cell line: new potential insight on their role in the setting of human health. 366
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 364
Functional ancient grain bread rich in iron, zinc, flavonoids and alpha lipoic acid attenuates post-ischemic myocardial remodeling in rats 360
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 358
The evolution of TAVI performance overtime: an overview of systematic reviews 354
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 353
[Central apneas and cardiovascular diseases] 347
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases. 347
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 346
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 346
La neuropatia diabetica 345
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 345
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 344
Tuscany Sangiovese Grape juice imparts cardioprotection by regulating gene expression of Cardioprotective C-Type Natriuretic Peptide. 340
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 339
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease 339
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 338
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 338
A longitudinal assessment of chronic care pathways in real-life: self-care and outcomes of chronic heart failure patients in Tuscany 337
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 337
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 337
Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: some results. 336
Prediction of the chemoreflex gain by common clinical variables in heart failure 336
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 335
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 334
Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin i 334
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 333
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 332
Ancient grain bread rich in iron, zinc, flavonoids and alpha lipoic acid as a novel preoperative functional food for suppressing the progression of cardiovascular remodeling in infarcted male rats 330
Treating chemoreflex in heart failure: modulation or demolition? 329
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 329
Natriuretic peptides expression in a murine model of myocardial infarction after Sangiovese grape juice intake. Focus on CNP and ON putative involvement of plant miRNAs in-vitro and in healthy humans 326
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 325
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 324
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 322
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 320
Adrenergic activation in heart failure: blockade or rebalance? 318
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 315
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 313
Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy 312
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 312
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 311
Eligibility for vericiguat in a real‐world, contemporary heart failure population 311
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 310
Biomarcatori di stabilità della placca aterosclerotica (Rassegna) 309
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 309
Acute right-sided transcutaneous vagus nerve stimulation improves cardio-vagal baroreflex gain in patients with chronic heart failure 308
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 308
Evaluation of analytical performance and comparison of clinical results of the new generation method AccuTnI+3 for the measurement of cardiac troponin I using both patients and quality control plasma samples 308
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 306
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 306
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 306
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias 306
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 305
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 304
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 304
Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: A cardiac MR study 303
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 302
Sympathetic and Vagal Nerve Activity in COPD: Pathophysiology, Presumed Determinants and Underappreciated Therapeutic Potential 301
Acute and persistent effects of a 46-kilometer wilderness trail run at altitude: cardiovascular autonomic modulation and baroreflexes. 301
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 299
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 299
Evaluation of analytical performance of a novel immunoenzymometric assay for cTnI. 298
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 297
Screening the health status of people working in a university 297
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE 297
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 297
A matter of sex—persistent predictive value of MECKI score prognostic power in men and women with heart failure and reduced ejection fraction: a multicenter study 295
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 294
Metabolic exercise data combined with cardiac and kidney indexes: MECKI score. Predictive role in cardiopulmonary exercise testing with low respiratory exchange ratio in heart failure 294
Renal denervation in resistant arterial hypertension: Effects on neurohormonal activation and cardiac natriuretic peptides 293
Bioinformatics analysis of the gene profile of coronary endothelial cells treated with Grapevine microRNAs: an in vitro study 293
How to take arms against central apneas in heart failure 292
Usefulness of high-sensitive troponin elevation after effort stress to unveil vulnerable myocardium in patients with hart failure 292
Cardiac biomarker testing in the clinical laboratory:Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. 290
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 290
RNA-targeting and gene editing therapies for transthyretin amyloidosis 289
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 289
Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure 287
Sex-related differences in chronic heart failure 287
Effects of central apneas on sympathovagal balance and hemodynamics at night: impact of underlying systolic heart failure 282
Totale 36.786
Salva come PNG Salva come JPEG
Categoria #
all - tutte 611.826
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 611.826
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.168 0 0 379 663 153 119 764 1.269 561 670 114 476
2022/20235.337 402 312 276 790 779 826 53 432 917 106 244 200
2023/20243.247 292 112 528 227 210 337 303 190 191 167 168 522
2024/202521.021 192 234 1.198 489 999 1.286 2.826 5.165 1.700 1.382 3.296 2.254
2025/202650.993 2.656 8.064 5.647 6.140 5.315 3.007 5.759 2.098 2.691 3.249 3.143 3.224
2026/20274.169 1.320 1.718 1.131 0 0 0 0 0 0 0 0 0
Totale 121.900